Drug
KP 001
KP 001: highest development phase Phase 3, developed by Kaken Pharmaceutical. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kaken Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| KP-001 NCT07285005 | Phase 3 | Venous Malformations |
Latest
No recent events.
Follow KP 001 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.